MBS item 73451 & 73452
As of 1 November 2023, 3-condition carrier screening for cystic fibrosis (CF), spinal muscular atrophy (SMA) and fragile X syndrome (FXS) is subsidised by Medicare.
MBS item 73451 & 73452
As of 1 November 2023, 3-condition carrier screening for cystic fibrosis (CF), spinal muscular atrophy (SMA) and fragile X syndrome (FXS) is subsidised by Medicare.